¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03
±³À°ÀÏÀÚ : 2020-09-03
±³À°Àå¼Ò : Àü³²´ëÇб³º´¿ø ¸íÇд밭´ç  
±³À°ÁÖÁ¦ : 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³² Áöȸ  
´ã´çÀÚ : ±è⼺
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : laminion@hanmail.net      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-03 ¸íÇд밭´ç 15:30~15:50 µî·Ï ¹× È£³²Áöȸ ȸÀå Àλ砠±è¼ö¿Ï(È£³²ÁöȸÀå) 
±âŸ 09-03 ¸íÇд밭´ç 15:50~16:00 ´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå Àλ砠¾çö¿ì(´ëÇѽÅÀåÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:00~16:25 A severe case of tenofovir-associated acute kidney injury requring hemodialysis in a patient with chronic B hepatitis  Á¶¾Æ¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 16:25~16:50 Xanthogranulomatous osteomyelitis of chest wall in a kidney transplantation patient  ÃÖÁ¾ÀÎ(Á¶¼±´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 16:50~17:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Interesting cases of kidney disease)  À̽Ä(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:00~17:25 ANCA associated vasculitides in a patient with positive serologic test for Hantan virus  ±èÇü¿Ï(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 17:25~17:50 A 2-year study on the combination therapy of angiotensin II receptor blocker and midrine for proteinuria reduction in patients with hypotension or normal blood pressure  °­Èñ¸²(¿ø±¤´ëÇб³º´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 17:50~18:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Hot issues of management of kideny disease)  ¸¶¼º±Ç(Àü³²´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 18:00~18:10 Coffee Break & Photo  () 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:10~18:35 Impact of obesity on the quality of life in patients with CKD  ¼­»óÇå(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-03 ¸íÇд밭´ç 18:35~19:00 God committee  À̱¤¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
Åä·Ð 09-03 ¸íÇд밭´ç 19:00~19:10 ÆгÎÅäÀÇ(ÁÖÁ¦: Emerging problems of ethical conflict)  ¾È¼±È£(¿ø±¤´ëÇб³º´¿ø) 
±âŸ 09-03 ¸íÇд밭´ç 19:10~19:20 Æóȸ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ Ãß°è½ÉÆ÷Áö¾ö : 2020-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Àü¸³¼±ºñ´ëÁõ, °ú¹Î¼º¹æ±¤) : 2020-09-03
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ¿Ü·¡¿¡¼­ ½ÃÇàÇÒ ¼ö ÀÖ´Â ºñ°ú °ü·Ã ÀçÈ° Ä¡·á : 2020-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
285 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) ÇǺΠÇ÷°ü Áúȯ 2) »ö¼Ò ÀÌ»óÁõ : 2018-09-27 0 793 2018-07-28
284 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(Æó¼â°¢ ³ì³»Àå) : 2018-09-21 0 1,431 2018-07-28
283 ´ë±¸ ´ëÇѽÅÀåÇÐȸ ´ë±¸-°æºÏÁöȸ ¿¬¼ö °­Á : 2018-09-20 0 678 2018-07-28
282 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-20 0 401 2018-07-28
281 ¼­¿ï [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] 4Â÷ »ê¾÷Çõ¸í°ú ÀÇ·áÀÇ ¹Ì·¡ : 2018-09-20 0 656 2018-07-28
280 ¼­¿ï ¼­¿ïƯº°½ÃÀÇ»çȸ Á¦5Â÷ ȸ¿ø¿¬¼ö±³À°(Áø´Ü¸í¿¡ µû¸¥ ÀûÀýÇÑ Ã³¹æ) : 2018-09-20 0 860 2018-07-28
279 °­¿ø ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø Á¦ 130ȸ ¼ÒÈ­±â¼¾ÅÍ ¿¬¼ö±³À° : 2018-09-19 0 751 2018-07-28
278 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-19 0 513 2018-07-28
277 ¼­¿ï ¼ÛÆı¸(4Â÷) °³¿øÀÇ ¿¬¼ö±³À°(¿äÅëȯÀÚ, °ñ´Ù°øÁõ) : 2018-09-18 0 518 2018-07-28
276 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¾È°úÁö¿ªÀÇ»ç Áý´ãȸ : 2018-09-18 0 549 2018-07-28
275 °æ±â Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø ³ì³»Àå : 2018-09-18 0 670 2018-07-28
274 ´ë±¸ ´ëÇѽŰæ°úÇÐȸ ´ë°æÁöȸ - ´ë°æ½Å°æ°úÀÇ»çȸ °øµ¿ ½ÉÆ÷Áö¿ò : 2018-09-18 0 1,522 2018-07-28
273 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-18 0 634 2018-07-28
272 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-17 0 449 2018-07-28
271 °æ±â Á¦ 1ȸ ¾ÆÁִ뺴¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-16 0 2,147 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷